Sponsor Pipeline

Genrix (Shanghai) Biopharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
15
Active Trials
6
Recruiting
5
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
5
Phase 2
3
Phase 1/2
4
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06635798 A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and… Tetanus Recruiting
NCT07154342 A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis Allergic Rhinitis, Seasonal Recruiting
NCT07452198 A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in… Multiple Myeloma Recruiting
NCT07199257 A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. Allergic Rhinitis, Seasonal Not Yet Recruiting
NCT06516302 A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps Active, Not Recruiting
Phase 2
NCT06952075 GR1803 Injection in Patients With RRMM Multiple Myleoma Recruiting
NCT06315426 A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). Allergic Rhinitis Active, Not Recruiting
NCT06566547 GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma Active, Not Recruiting
Phase 1/2
NCT07348055 A Study of GR1803 in Systemic Lupus Erythematosus Systemic Lupus Erthematosus Recruiting
NCT06015230 Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in… Lupus Erythematosus, Systemic Active, Not Recruiting
NCT07090954 A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the… Multiple Myeloma Not Yet Recruiting
NCT07647237 A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in… Vitiligo Not Yet Recruiting
Phase 1
NCT07199270 A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy… Health Adult Subjects Recruiting
NCT07190716 A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers. Single Ascending Dose Not Yet Recruiting
NCT07647224 A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial… Multiple Dose Not Yet Recruiting
Disease Areas
Get alerts when Genrix (Shanghai) Biopharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free